Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections....
Merck & Co., Inc. (MRK) has a valuation score of 90/100 (strong), profitability score of 82/100 (strong), financial health score of 67/100 (moderate), Piotroski F-Score of 4/9, Altman Z-Score of 3.49 (safe zone), revenue growth of +3.1% YoY.
Neutral
Analyst Consensus
BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026
Analyst Recommendations36 analysts · 2026-08-01
9
16
11
Strong Buy 9Buy 16Hold 11Sell 0Strong Sell 0
Recent Market Moves
See all MRK moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Aug 25 | Regular | $156.26 | +3.72% | 2.48 |
| Aug 25 | After-hours | $156.78 | +4.06% | 2.71 |
| Aug 19 | Pre-market | $145.59 | +7.71% | 5.14 |